SCHEMBL1744049

SCHEMBL1744049

Clc1cccc(-c2cccc(-c3cccc(Br)c3)c2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.50
TAAR1 Q96RJ0 2/20 0.48
ESR2 Q92731 1/20 0.46
GABRG2 P18507 4/20 0.45
GABRB3 P28472 4/20 0.45
GABRA5 P31644 4/20 0.45
GABRA3 P34903 4/20 0.45
GABRA1 P14867 3/20 0.45
GABRP O00591 2/20 0.45
GABRD O14764 2/20 0.45
GABRB1 P18505 2/20 0.45
GABRA2 P47869 2/20 0.45
GABRB2 P47870 2/20 0.45
GABRA4 P48169 2/20 0.45
GABRE P78334 2/20 0.45
GABRA6 Q16445 2/20 0.45
GABRG1 Q8N1C3 2/20 0.45
GABRG3 Q99928 2/20 0.45
GABRQ Q9UN88 2/20 0.45
MAOB P27338 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2275959 0.98 ALOX5 (0.48) ALOX5TAAR1ESR2GABRG2GABRB3
SCHEMBL29389647 0.98 ALOX5 (0.52) ALOX5TAAR1ESR2GABRG2GABRB3
SCHEMBL867900 0.98 ALOX5 (0.52) ALOX5TAAR1ESR2GABRG2GABRB3
SCHEMBL29468118 0.98 ALOX5 (0.52) ALOX5TAAR1ESR2GABRG2GABRB3
SCHEMBL29397674 0.98 ALOX5 (0.52) ALOX5TAAR1ESR2GABRG2GABRB3
SCHEMBL15624408 0.87 ALOX5 (0.41) ALOX5TAAR1ESR2GABRG2GABRB3
SCHEMBL17813623 0.86 RXRA (0.50) ALOX5TAAR1GABRG2GABRB3GABRA5
SCHEMBL15624388 0.85 ALDH1A1 (0.50) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL29398919 0.85 ALDH1A1 (0.50) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL29629014 0.85 ALOX5 (0.62) ALOX5TAAR1ESR2MAOBNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2385940-B1 2,4,6-TRI-(HETEROARYLPHENYL)-PYRIDINES AND ELECTRON-TRANSPORTING MATERIALS COMPRISING THEM GEN ELECTRIC (US) 2015-10-28 EP disclosed
CN-102272123-B Electron transport material and preparation method thereof GENERAL ELECTRIC CO. (US) 2015-09-23 CN disclosed
CN-102272122-B 2,4,6-tri-(heteroaryl-phenyl)-pyridine and the electron transport material comprising it GENERAL ELECTRIC CO. (US) 2015-09-16 CN disclosed
EP-2385941-B1 ELECTRON-TRANSPORTING MATERIALS COMPRISING AND PROCESSES FOR MAKING THE SAME GEN ELECTRIC (US) 2014-03-26 EP disclosed
CN-102272122-A 2,4,6-tri-(heteroarylphenyl)-pyridines and electron-transporting materials comprising them 2011-12-07 CN disclosed
CN-102272123-A Electron-transporting materials comprising and processes for making the same 2011-12-07 CN disclosed
EP-2385941-A1 ELECTRON-TRANSPORTING MATERIALS COMPRISING AND PROCESSES FOR MAKING THE SAME General Electric Company (US) 2011-11-16 EP disclosed
US-8039201-B2 Antireflective coating composition and process thereof AZ ELECTRONIC MATERIALS USA CORP. (US) 2011-10-18 US disclosed
WO-2010080472-A1 ELECTRON-TRANSPORTING MATERIALS COMPRISING AND PROCESSES FOR MAKING THE SAME GENERAL ELECTRIC COMPANY (US) 2010-07-15 WO disclosed
US-20100171078-A1 ELECTRON-TRANSPORTING MATERIALS AND PROCESSES FOR MAKING THE SAME GENERAL ELECTRIC COMPANY (US) 2010-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100171078-A1 ELECTRON-TRANSPORTING MATERIALS AND PROCESSES FOR MAKING THE SAME C3AR1, CRY1, C1S ALOX5 2035/4885TAAR1 229/4885ESR2 207/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.